Recognized Consensus Standards: Medical Devices
-
91 to 100 of 115 Results
Specialty Task Group Area: InVitro Diagnostics |
Results per Page |
Date of
Entry |
Specialty Task
Group Area |
Recognition
Number |
Extent of
Recognition |
Standards
Developing Organization |
Standard Designation Number and Date |
Standard Title (click for recognition information) |
12/20/2021 | InVitro Diagnostics | 7-310 | Complete | ISO | 19238 Second edition 2014-02-01 | Radiological protection - Performance criteria for service laboratories performing biological dosimetry by cytogenetics |
06/07/2021 | InVitro Diagnostics | 7-307 | Complete | CLSI | POCT05 2nd Edition | Performance Metrics for Continuous Interstitial Glucose Monitoring |
09/21/2016 | InVitro Diagnostics | 7-265 | Partial | CLSI | C62-A | Liquid Chromatography-Mass Spectrometry Methods; Approved Guideline. |
06/07/2021 | InVitro Diagnostics | 7-236 | Partial | CLSI | M43-A October 2011 | Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline |
01/14/2019 | InVitro Diagnostics | 7-269 | Partial | CLSI | MM23-1st Edition | Molecular Diagnostic Methods for Solid Tumors (Nonhematological Neoplasms) |
07/06/2020 | InVitro Diagnostics | 7-296 | Partial | CLSI | EP09c 3rd Edition | Measurement Procedure Comparison and Bias Estimation Using Patient Samples |
01/30/2014 | InVitro Diagnostics | 7-210 | Partial | CLSI | H26-A2 | Validation, Verification, and Quality Assurance of Automated Hematology Analyzers; Proposed Standard - Second Edition |
12/23/2016 | InVitro Diagnostics | 7-268 | Partial | CLSI | EP21 2nd Edition (Replaces EP21-A) | Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures |
12/18/2023 | InVitro Diagnostics | 7-320 | Partial | CLSI | H62 1st Edition | Validation of Assays Performed by Flow Cytometry |
07/15/2019 | InVitro Diagnostics | 7-289 | Partial | CLSI | MM17 2nd Edition | Verification and Validation of Multiplex Nucleic Acid Assays |
-